Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ozonolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a scalable, eco-friendly synthesis route for 4-acetoxy-2-azetidinone intermediates. Eliminate toxic reagents and reduce manufacturing costs for carbapenem production.
Patent CN103467270B details a safer ozonolysis route for 3-oxocyclobutanecarboxylic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Novel patent route from natural anethole offers high purity and cost efficiency for pharmaceutical manufacturing, replacing toxic cyanide processes.
Novel patent CN103319452B enables high-purity synthesis from byproducts ensuring cost reduction and supply chain stability for pharmaceutical intermediates manufacturing globally
Novel 4-step synthesis from dimethyl isophthalate offers high yield and purity for electronic component coatings, reducing purification complexity.
Novel synthetic route for Entecavir using Corey lactone diol, offering cost reduction and scalability for pharmaceutical manufacturing supply chains.
Patent CN113549102B reveals a thiourea-free ozone/CO method for removing p-methoxyphenyl groups, offering high purity and reduced sulfur waste for API manufacturing.
Patent CN102690252B details a novel Stiripentol synthesis route converting synthesis by-products into high-value epilepsy intermediates, offering significant cost and supply chain advantages.
Patent CN103641684A reveals a novel ozonolysis route for high-purity chlorohydrin. Achieve >99% purity with reduced environmental impact and simplified downstream processing for pharma applications.
Advanced synthesis of chiral heptenone intermediates via ozonolysis and HWE reaction. Offers cost-effective, scalable production for statin APIs with superior yield.
Discover the efficient CN114728874A patent process for Maxacalcitol. Achieve cost reduction in API manufacturing with scalable, high-purity vitamin D analog intermediates.
Patent CN112300184B details a high-yield route for racemic camptothecin intermediates. Discover cost-effective manufacturing and supply chain advantages for API production.
Patent CN112374976B details a 3-step route to (1E,4E)-1,5-bis(2-methoxyphenyl)pent-1,4-dien-3-one avoiding heavy metals and column chromatography for cost-effective manufacturing.
Patent CN110950745B details a green synthesis of phenylacetaldehyde via Lindlar hydrogenation and ozonation, offering high purity and supply chain stability.
Patent CN114805218B reveals a novel synthesis route for Rosuvastatin Calcium Intermediate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.